SPX4,265.22+57.95 1.38%
DIA337.05+3.34 1.00%
IXIC13,003.42+223.51 1.75%

--Morgan Stanley Raises Boston Scientific's Price Target to $49 From $46, Maintains Overweight Rating

--Morgan Stanley Raises Boston Scientific's Price Target to $49 From $46, Maintains Overweight Rating

MT Newswires · 07/28/2022 07:11

Please log in to view news